Tom Staab

Tom Staab joined the BioCryst Leadership Team in July 2011, bringing his skill and experience regarding the financial stewardship of publically-traded companies, development and commercialization of pharmaceutical products and raising capital through strategic partnerships, equity and debt financings. Mr. Staab most recently served as Executive Vice President, CFO and Treasurer of Inspire Pharmaceuticals from May 2003 through its $430 million acquisition by Merck & Co., Inc. in May 2011. Prior to joining Inspire, he held the senior financial positions of Acting CFO and Treasurer at Triangle Pharmaceuticals, Inc. through its $480 million acquisition by Gilead Sciences, Inc. Additionally, Mr. Staab spent eight years working for PricewaterhouseCoopers LLP providing audit and business advisory services to national and multi-national corporations in the biotechnology, pharmaceutical, pulp and paper and communications industries. Tom currently serves on the Board of the NC Biosciences Organization (NCBIO) and is a member of its Audit Committee, and he has received several awards for his contribution and leadership to other organizations. He is a Certified Public Accountant and received a B.S. in Business Administration and a Masters of Accounting from the University of North Carolina at Chapel Hill.

Education

• BS BA; MAC UNC Kenan-Flagler Business School (1985 — 1990)
• BSBA; MAC University of North Carolina at Chapel Hill (1985 — 1990)

Companies

• Chief Financial Officer LENSAR, Inc. (2020)
• Consultant Blue Heron Consultants LLC (2019)
• Section/Adjunct Professor UNC Kenan-Flagler Business School (2019)
• CFO and Treasurer BioCryst Pharmaceuticals, Inc. (2011 — 2020)
• Executive Vice President, CFO & Treasurer Inspire (2003 — 2011)
• CFO and Treasurer Inspire Pharmaceuticals (2003 — 2011)
• Vice President and Treasurer/Acting Chief Financial Officer Triangle Pharmaceuticals, Inc./Gilead Sciences, Inc., (1998 — 2003)
• Manager - TICE practice PricewaterhouseCoopers, LLP (1990 — 1998)